Patent · US Active

CGAS antagonist compounds

US11597707B2 · kind B2 · utility

1Cited by

14References

26Claims

0Family size

Assignees

ImmuneSensor Therapeutics, Inc. · US
The Board of Regents of the University of Texas System · US

Inventors

Boyu Zhong · Carmel, US
Lijun Sun · Harvard, US
Heping Shi · Dallas, US
Jing Li · Lansdale, US
Chuo Chen · Dallas, US
Zhijian Chen · Dallas, US

Key dates

Filing date	Mar 3, 2021
Grant date	Mar 7, 2023
Priority date	—
Expiry date	Mar 3, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are novel compounds of Formula I that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.